A detailed history of Brave Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Brave Asset Management Inc holds 3,195 shares of AMGN stock, worth $1.02 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
3,195
Previous 3,928 18.66%
Holding current value
$1.02 Million
Previous $1.12 Million 10.57%
% of portfolio
0.25%
Previous 0.29%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$262.75 - $319.31 $192,595 - $234,054
-733 Reduced 18.66%
3,195 $998,000
Q1 2024

Apr 29, 2024

SELL
$268.87 - $324.56 $36,028 - $43,491
-134 Reduced 3.3%
3,928 $1.12 Million
Q4 2023

Jan 18, 2024

SELL
$255.7 - $288.46 $6,392 - $7,211
-25 Reduced 0.61%
4,062 $1.17 Million
Q3 2023

Oct 13, 2023

SELL
$218.65 - $271.46 $35,202 - $43,705
-161 Reduced 3.79%
4,087 $1.1 Million
Q2 2023

Jul 24, 2023

BUY
$214.27 - $253.37 $12,641 - $14,948
59 Added 1.41%
4,248 $943,000
Q1 2023

Apr 12, 2023

BUY
$225.79 - $275.2 $270,496 - $329,689
1,198 Added 40.05%
4,189 $1.01 Million
Q4 2022

Jan 19, 2023

SELL
$229.03 - $291.01 $578,758 - $735,382
-2,527 Reduced 45.8%
2,991 $0
Q3 2022

Oct 13, 2022

SELL
$224.46 - $253.15 $10,325 - $11,644
-46 Reduced 0.83%
5,518 $1.24 Million
Q2 2022

Jul 15, 2022

SELL
$230.71 - $256.74 $2,076 - $2,310
-9 Reduced 0.16%
5,564 $1.35 Million
Q1 2022

Apr 22, 2022

SELL
$219.27 - $242.57 $8,332 - $9,217
-38 Reduced 0.68%
5,573 $1.35 Million
Q4 2021

Jan 21, 2022

SELL
$198.88 - $227.6 $3,977 - $4,552
-20 Reduced 0.36%
5,611 $1.26 Million
Q3 2021

Nov 02, 2021

SELL
$212.27 - $248.7 $49,883 - $58,444
-235 Reduced 4.01%
5,631 $1.2 Million
Q2 2021

Jul 27, 2021

SELL
$233.58 - $259.14 $96,702 - $107,283
-414 Reduced 6.59%
5,866 $1.43 Million
Q1 2021

Apr 26, 2021

BUY
$221.91 - $258.6 $288,261 - $335,921
1,299 Added 26.08%
6,280 $1.56 Million
Q4 2020

Jan 27, 2021

SELL
$216.38 - $257.67 $2.01 Million - $2.39 Million
-9,282 Reduced 65.08%
4,981 $1.15 Million
Q3 2020

Oct 19, 2020

BUY
$234.65 - $260.95 $49,745 - $55,321
212 Added 1.51%
14,263 $3.63 Million
Q2 2020

Jul 23, 2020

BUY
$197.81 - $242.74 $171,699 - $210,698
868 Added 6.58%
14,051 $3.31 Million
Q1 2020

Apr 16, 2020

BUY
$182.24 - $241.7 $39,181 - $51,965
215 Added 1.66%
13,183 $2.67 Million
Q4 2019

Jan 17, 2020

BUY
$189.21 - $243.2 $19,488 - $25,049
103 Added 0.8%
12,968 $3.13 Million
Q3 2019

Oct 24, 2019

SELL
$174.11 - $208.62 $65,639 - $78,649
-377 Reduced 2.85%
12,865 $2.49 Million
Q2 2019

Aug 05, 2019

BUY
$166.7 - $195.41 $113,189 - $132,683
679 Added 5.4%
13,242 $2.44 Million
Q1 2019

May 03, 2019

BUY
$180.87 - $203.88 $116,842 - $131,706
646 Added 5.42%
12,563 $2.39 Million
Q4 2018

Feb 04, 2019

SELL
$178.4 - $208.25 $34,609 - $40,400
-194 Reduced 1.6%
11,917 $2.32 Million
Q3 2018

Oct 23, 2018

BUY
$185.29 - $208.89 $4,076 - $4,595
22 Added 0.18%
12,111 $2.51 Million
Q2 2018

Jul 23, 2018

BUY
$166.05 - $186.51 $418,446 - $470,005
2,520 Added 26.34%
12,089 $2.23 Million
Q1 2018

Apr 26, 2018

BUY
$169.43 - $198.0 $5,930 - $6,930
35 Added 0.37%
9,569 $1.63 Million
Q4 2017

Feb 09, 2018

SELL
$168.79 - $188.59 $39,665 - $44,318
-235 Reduced 2.41%
9,534 $1.66 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $1.63 Million - $1.87 Million
9,769
9,769 $1.82 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Brave Asset Management Inc Portfolio

Follow Brave Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brave Asset Management Inc with notifications on news.